InfuSystems Holdings (INFU)
(Delayed Data from AMEX)
$5.97 USD
-0.49 (-7.59%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $5.96 -0.01 (-0.17%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INFU 5.97 -0.49(-7.59%)
Will INFU be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for INFU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INFU
Smith & Nephew (SNN) Partners InfuSystem for Renasys Edge
INFU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for INFU
Craig-Hallum Keeps Their Buy Rating on InfuSystem Holdings, Inc. (INFU)
InfuSystem’s Growth Trajectory and Expansion in Healthcare Services
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
Sanara MedTech and InfuSystem execute U.S. distribution agreement